P695: Uncertainty in interpretation of GAA variants detected through newborn screening without clinical manifestation of Pompe disease
Dona Kanavy(Duke University Health System), Catherine Rehder(Duke University), Taraka Donti(Baylor College of Medicine), Shelly Goomber(Duke University Health System), Yinghong Pan(Guangdong University of Technology), Raquel Fernández(American College of Medical Genetics), Filippo Pinto e Vairo(Mayo Clinic), Jennifer McGlaughon(Invitae (United States)), Deeksha Bali(MRC Epidemiology Unit), Xiangwen Chen‐Deutsch, Bryce A. Seifert(National Institute of Allergy and Infectious Diseases), Emily Kyle(American College of Medical Genetics), Jenny Goldstein, Meredith Weaver(American College of Medical Genetics), L. Clarke(University of British Columbia)
Cited by 0
Related Papers
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer
|Cell Reports|2016|320
Glycogen Storage Disease Type III diagnosis and management guidelines
|Genetics in Medicine|2010|305
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease
|Genetics in Medicine|2009|292
Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease
|Genetics in Medicine|2012|212